[go: up one dir, main page]

BR9611504A - Derivados de quinolina como inibidores de fosfodiesterase do tipo iv - Google Patents

Derivados de quinolina como inibidores de fosfodiesterase do tipo iv

Info

Publication number
BR9611504A
BR9611504A BR9611504A BR9611504A BR9611504A BR 9611504 A BR9611504 A BR 9611504A BR 9611504 A BR9611504 A BR 9611504A BR 9611504 A BR9611504 A BR 9611504A BR 9611504 A BR9611504 A BR 9611504A
Authority
BR
Brazil
Prior art keywords
type
phosphodiesterase inhibitors
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
BR9611504A
Other languages
English (en)
Inventor
Villar Esteban Pombo
Rainer Luond
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9611504A publication Critical patent/BR9611504A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9611504A 1995-11-14 1996-11-13 Derivados de quinolina como inibidores de fosfodiesterase do tipo iv BR9611504A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523267.4A GB9523267D0 (en) 1995-11-14 1995-11-14 Organic compounds
PCT/EP1996/004978 WO1997018208A1 (en) 1995-11-14 1996-11-13 Quinoline derivatives as type iv phosphodiesterase inhibitors

Publications (1)

Publication Number Publication Date
BR9611504A true BR9611504A (pt) 1999-03-02

Family

ID=10783856

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611504A BR9611504A (pt) 1995-11-14 1996-11-13 Derivados de quinolina como inibidores de fosfodiesterase do tipo iv

Country Status (17)

Country Link
EP (1) EP0873338A1 (pt)
JP (1) JPH11515000A (pt)
KR (1) KR19990067574A (pt)
CN (1) CN1202170A (pt)
AU (1) AU7570996A (pt)
BR (1) BR9611504A (pt)
CA (1) CA2235126A1 (pt)
CO (1) CO4770973A1 (pt)
CZ (1) CZ149498A3 (pt)
GB (1) GB9523267D0 (pt)
HU (1) HUP9903492A3 (pt)
MX (1) MX9803839A (pt)
PE (1) PE17598A1 (pt)
PL (1) PL326636A1 (pt)
SK (1) SK63998A3 (pt)
TR (1) TR199800851T2 (pt)
WO (1) WO1997018208A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287231B6 (sk) 1999-08-21 2010-04-07 Nycomed Gmbh Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
CN1537018A (zh) 2001-05-23 2004-10-13 田边制药株式会社 一种用于软骨疾病再生治疗的组合物
MXPA03010679A (es) 2001-05-23 2004-03-02 Tanabe Seiyaku Co Una composicion para acelerar la cicatrizacion de fractura osea.
WO2004087211A2 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
EP1713484A2 (en) * 2004-01-23 2006-10-25 Amgen Inc. Compounds and methods of use
JP2006347936A (ja) 2005-06-15 2006-12-28 Bayer Cropscience Ag 殺虫性ベンズアニリド類
WO2011143106A1 (en) 2010-05-10 2011-11-17 Gilead Sciences, Inc. Bi - functional pyrazolopyridine compounds
AU2011253203A1 (en) 2010-05-10 2012-11-22 Gilead Sciences, Inc. Bifunctional quinoline derivatives
ES2628365T3 (es) 2012-10-16 2017-08-02 Janssen Pharmaceutica N.V. Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T
SG11201502369XA (en) 2012-10-16 2015-05-28 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of ror-gamma-t
WO2014062655A1 (en) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
KR20160068956A (ko) 2013-10-15 2016-06-15 얀센 파마슈티카 엔.브이. RORyT의 퀴놀리닐 조절제
KR20160070133A (ko) 2013-10-15 2016-06-17 얀센 파마슈티카 엔.브이. RORyt의 알킬 결합 퀴놀리닐 조절제
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
WO2020005830A1 (en) * 2018-06-24 2020-01-02 Adama Agan Ltd. Process for the preparation of quinmerac

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines

Also Published As

Publication number Publication date
AU7570996A (en) 1997-06-05
JPH11515000A (ja) 1999-12-21
EP0873338A1 (en) 1998-10-28
WO1997018208A1 (en) 1997-05-22
CO4770973A1 (es) 1999-04-30
HUP9903492A3 (en) 2000-08-28
TR199800851T2 (xx) 1998-08-21
SK63998A3 (en) 1998-10-07
HUP9903492A2 (en) 2000-07-28
PL326636A1 (en) 1998-10-12
MX9803839A (es) 1998-09-30
CA2235126A1 (en) 1997-05-22
CN1202170A (zh) 1998-12-16
PE17598A1 (es) 1998-04-06
CZ149498A3 (cs) 1998-08-12
GB9523267D0 (en) 1996-01-17
KR19990067574A (ko) 1999-08-25

Similar Documents

Publication Publication Date Title
BR9611504A (pt) Derivados de quinolina como inibidores de fosfodiesterase do tipo iv
PT946512E (pt) Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos
PT818448E (pt) Cicloalcano-piridinas como inibidores da cetp
ATE215950T1 (de) Carbolinderivate
PT1095021E (pt) Derivados de quinolina
PT1073639E (pt) Derivados de quinolina
BR9611820A (pt) Derivados de quinolina
PT1049695E (pt) Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase
PT1001934E (pt) Compostos de indole como inibidores de cox-2
FI963228A7 (fi) Substituoituja bifenyylijohdannaisia fosfodiesteraasi-inhibiittoreina
MX9204425A (es) Derivados de quinazolina como inhibidores de la acetilcolinesterasa.
ATE229955T1 (de) Substituierte 1,8-naphthyridin-4(1h)-one als phosphodiesterase 4-inhibitoren
ATE229005T1 (de) Chinolinderivate
PT1226143E (pt) Derivados de imidazopiridina como inibidores da fosfodiesterase vii
DK0779887T3 (da) Hidtil ukendte benzimidazolderivater med CGMP-phosphodiesteraseinhiberende aktivitet
BR9702328A (pt) Derivados de 4-aralquilaminopirimidina bicíclicos como inibidores de quinase tirosina
NO991560L (no) PDE IV-inhiberende 2-cyanoiminoimidazol-derivater
PT1189907E (pt) Tienopirimidinas como inibidores da fosfodiesterase
PT1023268E (pt) Isoquinolinas como inibidores de uroquinase
PT1007512E (pt) 2-aminopiridinas alcoxi-substituidas ramificadas utilizadas como inibidores de nos
PT1075471E (pt) Derivados de indolilo como agentes seronergicos
PT1015446E (pt) Derivados de (4-piperidinil)-1h-2-benzopirano uteis como agentes antipsicoticos
NO994386D0 (no) 2-substituerte benzoylcykloalkyl-1-karboksylsyrederivater
PT1121349E (pt) Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta
PT1066284E (pt) Derivados de benzo [c] quinolizina e sua utilizacao como inibidores de 5-alfa-redutases

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law